Cargando…

Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States

BACKGROUND: There are disparities in influenza and pneumococcal vaccination rates among elderly minority groups and little guidance as to which intervention or combination of interventions to eliminate these disparities is likely to be most cost-effective. Here, we evaluate the cost-effectiveness of...

Descripción completa

Detalles Bibliográficos
Autores principales: Michaelidis, Constantinos I, Zimmerman, Richard K, Nowalk, Mary Patricia, Smith, Kenneth J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223514/
https://www.ncbi.nlm.nih.gov/pubmed/25023889
http://dx.doi.org/10.1186/1471-2458-14-718
_version_ 1782343206997852160
author Michaelidis, Constantinos I
Zimmerman, Richard K
Nowalk, Mary Patricia
Smith, Kenneth J
author_facet Michaelidis, Constantinos I
Zimmerman, Richard K
Nowalk, Mary Patricia
Smith, Kenneth J
author_sort Michaelidis, Constantinos I
collection PubMed
description BACKGROUND: There are disparities in influenza and pneumococcal vaccination rates among elderly minority groups and little guidance as to which intervention or combination of interventions to eliminate these disparities is likely to be most cost-effective. Here, we evaluate the cost-effectiveness of four hypothetical vaccination programs designed to eliminate disparities in elderly vaccination rates and differing in the number of interventions. METHODS: We developed a Markov model in which we assumed a healthcare system perspective, 10-year vaccination program and lifetime time horizon. The cohort was the combined African-American and Hispanic 65 year-old birth cohort in the United States in 2009. We evaluated five different vaccination strategies: no vaccination program and four vaccination programs that varied from “low intensity” to “very high intensity” based on the number of interventions deployed in each program, their cumulative cost and their cumulative impact on elderly minority influenza and pneumococcal vaccination rates. RESULTS: The very high intensity vaccination program ($24,479/quality-adjusted life year; QALY) was preferred at willingness-to-pay-thresholds of $50,000 and $100,000/QALY and prevented 37,178 influenza cases, 342 influenza deaths, 1,158 invasive pneumococcal disease (IPD) cases and 174 IPD deaths over the birth cohort’s lifetime. In one-way sensitivity analyses, the very high intensity program only became cost-prohibitive (>$100,000/QALY) at less likely values for the influenza vaccination rates achieved in year 10 of the high intensity (>73.5%) or very high intensity (<76.8%) vaccination programs. CONCLUSIONS: A practice-based vaccination program designed to eliminate disparities in elderly minority vaccination rates and including four interventions would be cost-effective.
format Online
Article
Text
id pubmed-4223514
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42235142014-11-08 Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States Michaelidis, Constantinos I Zimmerman, Richard K Nowalk, Mary Patricia Smith, Kenneth J BMC Public Health Research Article BACKGROUND: There are disparities in influenza and pneumococcal vaccination rates among elderly minority groups and little guidance as to which intervention or combination of interventions to eliminate these disparities is likely to be most cost-effective. Here, we evaluate the cost-effectiveness of four hypothetical vaccination programs designed to eliminate disparities in elderly vaccination rates and differing in the number of interventions. METHODS: We developed a Markov model in which we assumed a healthcare system perspective, 10-year vaccination program and lifetime time horizon. The cohort was the combined African-American and Hispanic 65 year-old birth cohort in the United States in 2009. We evaluated five different vaccination strategies: no vaccination program and four vaccination programs that varied from “low intensity” to “very high intensity” based on the number of interventions deployed in each program, their cumulative cost and their cumulative impact on elderly minority influenza and pneumococcal vaccination rates. RESULTS: The very high intensity vaccination program ($24,479/quality-adjusted life year; QALY) was preferred at willingness-to-pay-thresholds of $50,000 and $100,000/QALY and prevented 37,178 influenza cases, 342 influenza deaths, 1,158 invasive pneumococcal disease (IPD) cases and 174 IPD deaths over the birth cohort’s lifetime. In one-way sensitivity analyses, the very high intensity program only became cost-prohibitive (>$100,000/QALY) at less likely values for the influenza vaccination rates achieved in year 10 of the high intensity (>73.5%) or very high intensity (<76.8%) vaccination programs. CONCLUSIONS: A practice-based vaccination program designed to eliminate disparities in elderly minority vaccination rates and including four interventions would be cost-effective. BioMed Central 2014-07-15 /pmc/articles/PMC4223514/ /pubmed/25023889 http://dx.doi.org/10.1186/1471-2458-14-718 Text en Copyright © 2014 Michaelidis et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Michaelidis, Constantinos I
Zimmerman, Richard K
Nowalk, Mary Patricia
Smith, Kenneth J
Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States
title Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States
title_full Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States
title_fullStr Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States
title_full_unstemmed Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States
title_short Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States
title_sort cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the united states
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223514/
https://www.ncbi.nlm.nih.gov/pubmed/25023889
http://dx.doi.org/10.1186/1471-2458-14-718
work_keys_str_mv AT michaelidisconstantinosi costeffectivenessofprogramstoeliminatedisparitiesinelderlyvaccinationratesintheunitedstates
AT zimmermanrichardk costeffectivenessofprogramstoeliminatedisparitiesinelderlyvaccinationratesintheunitedstates
AT nowalkmarypatricia costeffectivenessofprogramstoeliminatedisparitiesinelderlyvaccinationratesintheunitedstates
AT smithkennethj costeffectivenessofprogramstoeliminatedisparitiesinelderlyvaccinationratesintheunitedstates